Please login to the form below

Not currently logged in
Email:
Password:

medicines use

This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.

EU files WTO dispute with Turkey over pharma laws

EU files WTO dispute with Turkey over pharma laws

Country breaks WTO obligations. Turkey is breaking World Trade Organisation (WTO) rules by allowing reimbursement for medicines only if they are produced within the country, says the EU. ... From 2016, the Turkish government implemented a project to

Latest news

  • Pharma fears “lack of focus” on no-deal Brexit preparations Pharma fears “lack of focus” on no-deal Brexit preparations

    As a matter of urgency, it is important that EU member states allow the use of medicines that have been quality tested in the UK where companies have been unable to ... Medical devices used alongside medicines that currently hold UK certified CE marks,

  • FDA and Flatiron extend real world evidence collaboration FDA and Flatiron extend real world evidence collaboration

    Set up by US tech entrepreneurs Nat Turner and Zach Weinberg in 2012, Flatiron has pioneered the use of electronic health records (EHRs) to help inform research and patient care, starting ... read notes written by doctors about patients, their medicines

  • Greater Manchester backs move to outcome-based payment Greater Manchester backs move to outcome-based payment

    Partnering with Cancer Research UK is a phenomenal opportunity to continue working towards reducing the use of medicines that are not giving people the benefits they need, ensuring that patients are ... able to access new and innovative medicines as

  • Novartis aims for 10 blockbuster launches by 2020 Novartis aims for 10 blockbuster launches by 2020

    Narasimhan is pushing the company towards a tighter focus on the most innovative medicines and leadership in digital innovation. ... Some of these are entirely new products, while others are expected significant expansions of use of existing medicines

  • Business warning as talk of Brexit ‘No deal’ grows Business warning as talk of Brexit ‘No deal’ grows

    Asked for its views, a spokesperson for the UK pharma industry association the ABPI said it reiterated its message from 7 December, when the health secretary Matt Hancock issued medicines-specific ... and the need for a significant increase in the use of

More from news
Approximately 0 fully matching, plus 249 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 33 partially matching documents found.

Latest appointments

  • ABPI Scotland appoints Sandra Auld as director ABPI Scotland appoints Sandra Auld as director

    the access to and use of new and innovative medicines for Scottish patients. . ... and innovative medicines.”.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions

  • EAHP elects Joan Peppard as president EAHP elects Joan Peppard as president

    As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.

  • Marschall Runge joins Lilly’s board of directors Marschall Runge joins Lilly’s board of directors

    Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare ... His appreciation of the importance of scientific research,

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • NHS medicines optimisation milestone

    by 2020/21 if the NHS embraces the use of best value biological medicines in a proactive, systematic and safe way’. ... The best biologics agenda and pharma. In line with the Commissioning Framework for Biological Medicines, NHS England, NHS

  • Patient Engagement and Experience Conference, 16-17 May

    The conference brings together HCPs, patients, payers, government, pharma and industry under one roof to focus on patients’ engagement and experience of their treatment to improve the real-world use of ... medicines.Speaking at the conference .

  • "Legal highs" ruling leaves illegal labs laughing

    There is a huge amount of off-label use of licensed medicines by medically qualified prescribers. ... There are also many agents that have crossed the line from illegal to legal use, such as cannabinoids for MS, as well as previously approved medicines

  • Making good practice common practice in rare disease

    Good listeners use a number of techniques - here are two simple examples you can try yourself:. ... Researchers found that the size of the drawing predicted speed of return to work, cardiac anxiety, use of alternative medicines and number of phone calls

  • Brexit and Pharma: A match made in hell.

    At the start of my career, the Irish Medicines Board (now the HPRA) licenced new products. ... Over the past 22 years, the EMA has been responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics